SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-22-006888
Filing Date
2022-03-22
Accepted
2022-03-22 16:12:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 xfor3212022.htm 424B5 13219
2 image_0a.jpg GRAPHIC 29026
  Complete submission text file 0001628280-22-006888.txt   54413
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-242372 | Film No.: 22759643
SIC: 2836 Biological Products, (No Diagnostic Substances)